A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
Hoffmann-La Roche
Novartis
Syndax Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Instituto Nacional de Cancer, Brazil
University of Kansas Medical Center
BBB-Therapeutics B.V.
University College, London
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Faculdade de Medicina do ABC
Medco Health Solutions, Inc.